Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.97 USD
-0.04 (-4.15%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $0.96 -0.01 (-0.83%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.46 | -8.70% |
Earnings Summary
For their last quarter, Adial Pharmaceuticals (ADIL) reported earnings of -$0.59 per share, missing the Zacks Consensus Estimate of -$0.39 per share. This reflects a negative earnings surprise of 51.28%. Look out for ADIL's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year increase of 59.65%.
Earnings History
Price & Consensus
Zacks News for ADIL
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services